Patents Assigned to Linc Invest AB
  • Use of hyaluronidase in the manufacturing of a drug for the treatment of inflammation
    Patent number: 6572855
    Abstract: Hyaluronidase is used in the treatment of inflammation associated with an increased local synthesis of hyaluronan in a mammal, e.g. in connection with organ grafting, hyaluronidase being administered locally or systemically. The effect is to reduce inflammatory cell infiltration.
    Type: Grant
    Filed: January 7, 2000
    Date of Patent: June 3, 2003
    Assignee: Linc Invest AB
    Inventors: Cecilia Johnsson, Gunnar Tufveson, Roger Hällgren, Bengt Gerdin